Ph.D. Camille Mailhac

Ph.D. Camille Mailhac has a diverse work experience in various scientific and research roles. Ph.D. Camille started their career at ASTBTP13 as an Archivist, where they were responsible for storing, classifying, and labeling confidential documents. Ph.D. Camille then worked as a Communication Manager at AssoM, the largest student association in Marseille, organizing cultural events and sports activities.

Camille then transitioned to the research field, starting as a Research Assistant at CNRS-LCB for a short period of time. Ph.D. Camille then joined Antitope Ltd as a Research Assistant and later as a Research Scientist, focusing on immunology research.

In 2014, they joined INSERM as an R&D Scientist, where they conducted scientific research in the field of molecular biology. Ph.D. Camille'srole involved planning and conducting studies, analyzing results, and presenting progress to clients.

After their tenure at INSERM, Camille joined HalioDx, a company specializing in immune response to cancer diagnostics. As a Scientist in product development, they contributed to the development of new in vitro diagnostic tools using NGS and IHC technologies. Ph.D. Camille was responsible for planning and executing development tests, analyzing results, and presenting technical progress and project updates to clients.

Currently, Camille is working at Enterome as a Scientist, where they continue their scientific research.

Ph.D. Camille Mailhac has a diverse education history. Ph.D. Camille obtained a Doctor - PhD degree in Biology and Immunology from Aix-Marseille University from 2014 to 2017. Prior to that, they pursued a Master of Engineering (M.Eng.) in Biotechnology from 2011 to 2013 at ESIL/Polytech'MARSEILLE, where they focused on coursework in cellular molecular biology, biochemistry, and protein purification. Ph.D. Camille also completed a Licence 3 degree from Université de Bordeaux in 2009. In the earlier years of their education, from 2006 to 2008, they attended Medical University Bordeaux II for their first year of medical school, known as PCEM1.